Adverse selection? A multi-dimensional profile of people dispensed opioid analgesics for persistent non-cancer pain

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Rogers, Kris D ^a,b   Kemp, Anna ^c   McLachlan, Andrew J ^d,e   Blyth, Fiona ^a,b,e  

^a SAX INSTITUTE   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e ANZAC Research Institute   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

NARCOTIC ANALGESIC AGENT; PARACETAMOL;

ADULT; AGED; ARTICLE; DISEASE ASSOCIATION; DISTRESS SYNDROME; DRUG USE; DRUG UTILIZATION; FEMALE; HEALTH CARE SYSTEM; HEALTH INSURANCE; HUMAN; LONG TERM CARE; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MIDDLE AGED; OSTEOARTHRITIS; PAIN; PERSISTENT NON CANCER PAIN; PHYSICAL DISABILITY; PRESCRIPTION; RURAL AREA; SELF REPORT; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; AUSTRALIA; DRUG PRESCRIPTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN; PAIN MANAGEMENT; RETROSPECTIVE STUDIES;

EID: 84891599446     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080095     Document Type: Article

References (28)

1. Cerdá M, Ransome Y, Keyes KM, Koenen KC, Tracy M, et al. (2013) Prescription opioid mortality trends in New York City, 1990-2006: Examining the emergence of an epidemic. Drug and Alcohol Dependence.
2. Dhalla IA, Mamdani MM, Sivilotti MLA, Kopp A, Qureshi O, et al. (2009) Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone. Can Med Assoc J 181: 891-896.
3. Khademi H, Malekzadeh R, Pourshams A, Jafari E, Salahi R, et al. (2012) Opium use and mortality in Golestan Cohort Study: prospective cohort study of 50 000 adults in Iran. BMJ 344.
4. Longman C, Lintzeris N, Temple-Smith M, Gilchrist G (2011) Methadone and buprenorphine prescribing patterns of Victorian general practitioners: their first 5 years after authorisation. Drug Alcohol Rev 30: 355-359.
5. Roxburgh A, Bruno R, Larance B, Burns L (2011) Prescription of opioid analgesics and related harms in Australia. Med J Aust 195: 280-284.
6. Leong M, Murnion B, Haber PS (2009) Examination of opioid prescribing in Australia from 1992 to 2007. Intern Med J 39: 676-681.
7. Harrison CM, Charles J, Henderson J, Britt H (2012) Opioid prescribing in Australian general practice. Med J Aust 196: 380-381.
8. Sullivan MD (2010) Who gets high-dose opioid therapy for chronic non-cancer pain? Pain 151: 567-568.
9. Andersen R, Newman JF (2005) Societal and Individual Determinants of Medical Care Utilization in the United States. Milbank Quarterly 83: Online-only-Online-only.
10. Banks E, Redman S, Jorm L, Armstrong B, Bauman A, et al. (2008) Cohort profile: the 45 and up study. Int J Epidemiol 37: 941-947.
11. Hynd A, Roughead EE, Preen DB, Glover J, Bulsara M, et al. (2008) The impact of co-payment increases on dispensings of government-subsidised medicines in Australia. Pharmacoepidemiol Drug Saf 17: 1091-1099.
12. Australian Government Department of Health and Aged Care (2011) Expenditure and prescriptions twelve months to 30 June 2011. Canberra.
13. Korff MV, Saunders K, Thomas Ray G, Boudreau D, Campbell C, et al. (2008) De facto long-term opioid therapy for noncancer pain. Clin J Pain 24: 521-527.
14. McManus P, Birkett DJ, Mant A (1998) Prescription use by patients with concession cards. Med J Aust 169: 285-286.
15. Medicare Australia (2008) Authority prescriptions. October 2007 ed. pp. homepage on the internet.
16. Boudreau D, Von Korff M, Rutter CM, Saunders K, Ray GT, et al. (2009) Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiology and Drug Safety 18: 1166-1175.
17. Australian Government Department of Health and Aged Care (2001) Measuring Remoteness: Accessibility/Remoteness Index of Australia (ARIA). Canberra.
18. Stewart AL, Kamberg CJ (1992) Physical functioning measures. In: A.L S, editor. Measuring functioning and well-being: the Medical Outcomes Study approach. Durham NC, USA: Duke University Press pp. 86-101.
19. Andrews G, Slade T (2001) Interpreting scores on the Kessler Psychological Distress Scale (K10). Aust N Z J Public Health 25: 494-497.
20. Simpson EH (1949) Measurement of diversity. Nature 163: 688.
21. Zou G (2004) A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol 159: 702-706.
22. Chapman CR, Lipschitz DL, Angst MS, Chou R, Denisco RC, et al. (2010) Opioid pharmacotherapy for chronic non-cancer pain in the United States: a research guideline for developing an evidence-base. J Pain 11: 807-829.
23. Braden JB, Fan MY, Edlund MJ, Martin BC, DeVries A, et al. (2008) Trends in use of opioids by noncancer pain type 2000-2005 among Arkansas Medicaid and HealthCore enrollees: results from the TROUP study. J Pain 9: 1026-1035.
24. Edlund MJ, Martin BC, Devries A, Fan MY, Braden JB, et al. (2010) Trends in use of opioids for chronic noncancer pain among individuals with mental health and substance use disorders: the TROUP study. Clin J Pain 26: 1-8.
25. Blyth FM, March LM, Cousins MJ (2003) Chronic pain-related disability and use of analgesia and health services in a Sydney community. Med J Aust 179: 84-87.
26. Alam A, Gomes T, Zheng H, Mamdani MM, Juurlink DN, et al. (2012) Long-term analgesic use after low-risk surgery: a retrospective cohort study. Arch Intern Med 172: 425-430.
27. Mealing NM, Banks E, Jorm LR, Steel DG, Clements MS, et al. (2010) Investigation of relative risk estimates from studies of the same population with contrasting response rates and designs. BMC Med Res Methodol 10: 26.
28. Australian Government Department of Health and Aged Care (2008) Expenditure and prescriptions twelve months to 30 June 2008. Canberra.